The automotive safety giant posted historic sales and cash flow in 2025, powered by explosive growth with Chinese automakers and in India. While navigating a softer production forecast and tariff headwinds, management projects margin expansion for 2026.
In a fiery address to the U.S. Conference of Mayors, Minneapolis Mayor Jacob Frey called on local leaders nationwide to resist what he described as aggressive federal immigration enforcement, arguing such operations undermine public safety and constitutional rights.
A new lawsuit alleging wrongful termination and safety cover-ups, coupled with ongoing supply shortages, challenges the coffee giant's operational resilience and brand trust as its new CEO executes a critical recovery plan.
While Medicare provides a crucial safety net at 65, significant gaps in coverage for dental, vision, and long-term care can lead to six-figure annual expenses. Proactive planning with HSAs, specialized insurance, and strategic budgeting is essential to protect retirement savings.
Synthetic biology leader Twist Bioscience reported strong Q1 FY2026 results, with revenue climbing 17% year-over-year to $103.7 million. Management highlighted accelerating demand from AI-powered drug discovery and reiterated its path to adjusted EBITDA breakeven by Q4 FY2026.
As the United States approaches its 250th anniversary, USA TODAY examines the enduring legacy of the companies that shaped the nation's culture, economy, and global identity.
New federal data reveals a significant year-over-year jump in energy costs for November, with natural gas prices soaring and electricity rates climbing, squeezing household budgets amid fluctuating demand and generation patterns.
While savings accounts offer safety and liquidity, experts warn that historically low interest rates are silently eroding purchasing power. We examine the risks of idle cash and explore strategies to protect—and grow—your nest egg.
Amid persistent inflation and shifting trade policies, building a robust financial safety net is more crucial than ever. Experts outline actionable steps to grow your savings, from debt management to smart account allocation.
The Walt Disney Company posted stronger-than-expected fiscal first-quarter results, with revenue climbing to $25.98 billion. However, a costly autumn carriage dispute with YouTube TV shaved $110 million from operating income, even as the company's Experiences division and streaming services showed robust growth. All eyes are now on the board's imminent decision on CEO Bob Iger's successor.
Merck & Co. shares have delivered impressive multi-year returns, climbing over 80% in the past five years. Yet, a deep dive into its valuation metrics suggests the market may still be underestimating the pharmaceutical leader's intrinsic value, presenting a potential opportunity for investors.
Lyft shares have dramatically outperformed the S&P 500, climbing nearly 20% in six months. While rider growth and improving cash flow paint an optimistic picture, underlying margin pressures reveal the intense competition in the ride-hailing sector.
The construction and maintenance services industry delivered a robust third quarter, with several key players exceeding revenue expectations despite economic headwinds. MYR Group and Comfort Systems stood out with strong beats, while the sector overall demonstrated pricing power and steady demand.
Mitsubishi UFJ Financial Group's shares have surged nearly 50% in the past year, capping a remarkable five-year run. As the stock trades near ¥2,751, investors are divided: does the valuation still offer a margin of safety, or has the rally run its course? We delve into the metrics and market sentiment.
RATIONAL AG's stock has seen a notable 12% climb on the XTRA exchange in recent months, reigniting investor debate. Our analysis suggests the shares may now be overvalued, trading above intrinsic value. We examine the outlook, growth potential, and whether investors should wait for a better entry point.
Nepali authorities have arrested six executives from travel and rescue companies, alleging a sophisticated fraud scheme involving fabricated high-altitude rescues to bilk international insurers out of nearly $20 million.
Swiss ventilation specialist Zehnder Group shows compelling operational improvements, with its Return on Capital Employed (ROCE) climbing significantly despite stable investment levels. This trend suggests a more efficient business model, potentially underpinning future growth.
Israel announces a limited, security-heavy reopening of Gaza's Rafah crossing with Egypt, allowing some medical evacuations while concerns mount over aid access and the safety of returnees.
Exclusive testimony from Dr. Mohamed Ibrahim, who fled the last hospital in Sudan's strategic el-Fasher, details a three-day ordeal of hiding from paramilitary forces, witnessing mass casualties, and surviving a kidnapping and ransom demand—shedding light on a siege the U.N. calls a 'massive crime scene.'
Gilead Sciences (NasdaqGS:GILD) reported positive Phase 3 ASCENT-04/KEYNOTE-D19 results for Trodelvy plus Keytruda in first-line metastatic triple-negative breast cancer. Full Phase 3 clinical data were published in a leading medical journal, highlighting efficacy and safety outcomes for the combination regimen. Following these results, Gilead submitted supplemental regulatory filings to the FDA and EMA seeking expanded use of Trodelvy in this setting. For you as an investor, this update...
